glp 1 drugs and autoimmune disease How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments Glucagon-like peptide and its receptor
Description
Scientific Reports
Tirzepatide follows a similar pattern, with indications spanning glycemic control and obesity treatment
However, this concern is not supported by larger and more systematic analyses of short-term data from clinical trials and observational studies
In addition to this, GLP-1 agonists are not safe to take if pregnant or breastfeeding
GLP-1, an incretin hormone, is synthesized in the brainstem, pancreas, and intestines, playing a crucial role in postprandial blood sugar regulation
In the vast majority of trials, symptoms are evaluated by participant self-report that, while simple, has major limitations (26)
